ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 10 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 3E0F76Z | Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F77Z | Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F7BZ | Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F7DZ | Introduction of Inhalation Anesthetic into Respiratory Tract, Via Natural or Artificial Opening through FY2017 | Retired |
| 3E0F7GC | Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F7HZ | Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F7KZ | Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F7SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F7SF | Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F7TZ | Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening | Valid |
| 3E0F804 | Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F805 | Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F80M | Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F828 | Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F829 | Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F83Z | Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F86Z | Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F87Z | Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F8BZ | Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F8DZ | Introduction of Inhalation Anesthetic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic through FY2017 | Retired |
| 3E0F8GC | Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F8HZ | Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F8KZ | Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F8SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F8SF | Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0F8TZ | Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G304 | Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Percutaneous Approach | Valid |
| 3E0G305 | Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach | Valid |
| 3E0G30M | Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach | Valid |
| 3E0G328 | Introduction of Oxazolidinones into Upper GI, Percutaneous Approach | Valid |
| 3E0G329 | Introduction of Other Anti-infective into Upper GI, Percutaneous Approach | Valid |
| 3E0G33Z | Introduction of Anti-inflammatory into Upper GI, Percutaneous Approach | Valid |
| 3E0G36Z | Introduction of Nutritional Substance into Upper GI, Percutaneous Approach | Valid |
| 3E0G37Z | Introduction of Electrolytic and Water Balance Substance into Upper GI, Percutaneous Approach | Valid |
| 3E0G3BZ | Introduction of Anesthetic Agent into Upper GI, Percutaneous Approach | Valid |
| 3E0G3GC | Introduction of Other Therapeutic Substance into Upper GI, Percutaneous Approach | Valid |
| 3E0G3HZ | Introduction of Radioactive Substance into Upper GI, Percutaneous Approach | Valid |
| 3E0G3KZ | Introduction of Other Diagnostic Substance into Upper GI, Percutaneous Approach | Valid |
| 3E0G3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Percutaneous Approach | Valid |
| 3E0G3SF | Introduction of Other Gas into Upper GI, Percutaneous Approach | Valid |
| 3E0G3TZ | Introduction of Destructive Agent into Upper GI, Percutaneous Approach | Valid |
| 3E0G4GC | Introduction of Other Therapeutic Substance into Upper GI, Percutaneous Endoscopic Approach | Valid |
| 3E0G704 | Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G705 | Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G70M | Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G728 | Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G729 | Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G73Z | Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G76Z | Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G77Z | Introduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G7BZ | Introduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G7GC | Introduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G7HZ | Introduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G7KZ | Introduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G7SF | Introduction of Other Gas into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G7TZ | Introduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening | Valid |
| 3E0G804 | Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G805 | Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G80M | Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G828 | Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G829 | Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G83Z | Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G86Z | Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G87Z | Introduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G8BZ | Introduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G8GC | Introduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G8HZ | Introduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G8KZ | Introduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G8SF | Introduction of Other Gas into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0G8TZ | Introduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H304 | Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Percutaneous Approach | Valid |
| 3E0H305 | Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach | Valid |
| 3E0H30M | Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach | Valid |
| 3E0H328 | Introduction of Oxazolidinones into Lower GI, Percutaneous Approach | Valid |
| 3E0H329 | Introduction of Other Anti-infective into Lower GI, Percutaneous Approach | Valid |
| 3E0H33Z | Introduction of Anti-inflammatory into Lower GI, Percutaneous Approach | Valid |
| 3E0H36Z | Introduction of Nutritional Substance into Lower GI, Percutaneous Approach | Valid |
| 3E0H37Z | Introduction of Electrolytic and Water Balance Substance into Lower GI, Percutaneous Approach | Valid |
| 3E0H3BZ | Introduction of Anesthetic Agent into Lower GI, Percutaneous Approach | Valid |
| 3E0H3GC | Introduction of Other Therapeutic Substance into Lower GI, Percutaneous Approach | Valid |
| 3E0H3HZ | Introduction of Radioactive Substance into Lower GI, Percutaneous Approach | Valid |
| 3E0H3KZ | Introduction of Other Diagnostic Substance into Lower GI, Percutaneous Approach | Valid |
| 3E0H3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Percutaneous Approach | Valid |
| 3E0H3SF | Introduction of Other Gas into Lower GI, Percutaneous Approach | Valid |
| 3E0H3TZ | Introduction of Destructive Agent into Lower GI, Percutaneous Approach | Valid |
| 3E0H4GC | Introduction of Other Therapeutic Substance into Lower GI, Percutaneous Endoscopic Approach | Valid |
| 3E0H704 | Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H705 | Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H70M | Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H728 | Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H729 | Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H73Z | Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H76Z | Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H77Z | Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H7BZ | Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H7GC | Introduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening | Valid |